Established Risks of Long-Term Zopiclone Use
Long-term zopiclone use carries significant risks including dependence, withdrawal symptoms, tolerance, cognitive impairment, and increased risk of falls, which outweigh potential benefits beyond short-term use. 1, 2
Primary Risks
Dependence and Withdrawal
- Physical and psychological dependence can develop with prolonged use 2
- Withdrawal symptoms may include:
- Anxiety
- Abnormal dreams
- Hyperesthesia
- Neurosis
- Rebound insomnia (temporary worsening of sleep parameters)
- In severe cases: palpitations, sweating, irritability, hallucinations, and impulsive behavior 3
Tolerance
- Diminished effectiveness over time requiring increased dosages 2
- Clinical data on tolerance development are conflicting, with some studies showing no development of tolerance over 4-week periods, while longer-term studies suggest tolerance may develop 4
Cognitive and Psychomotor Impairment
- Morning-after effects including:
- Reduced concentration
- Impaired memory
- Decreased psychomotor function (especially within 4-5 hours of dosing) 2
- Confusion and memory impairment more common in elderly patients 2
Sleep-Related Behaviors
- Risk for serious injuries from complex sleep behaviors:
- Sleepwalking
- Sleep driving
- Other activities while not fully awake 1
Additional Risks
Falls and Injuries
- Increased risk of falls, particularly in elderly patients 5
- Heightened risk when combined with other sedating medications 5
Abuse Potential
- Schedule IV controlled substance with abuse potential similar to benzodiazepines 2
- Higher risk in patients with history of substance abuse 6
- Case reports document extreme cases of abuse (doses up to 112.5 mg/day, 15 times the recommended dose) 3
Drug Interactions
- Dangerous respiratory depression when combined with opioids 1
- Cumulative and synergistic effects on respiratory depression when combined with benzodiazepines 1
Clinical Implications
Recommended Duration
- Zopiclone should be prescribed for short-term use only (≤4 weeks) 7
- Long-term use is not recommended by clinical guidelines 1, 5
Discontinuation Protocol
- Gradual tapering is necessary to prevent withdrawal symptoms 2
- Withdrawal effects are typically mild and resolve within 1-2 nights after discontinuation 2
- More severe cases may require supervised withdrawal with substitute medications 3
Monitoring Considerations
- Regular assessment for signs of dependence and tolerance
- Evaluation of continued efficacy
- Monitoring for cognitive and psychomotor impairment, especially in elderly patients
Alternative Approaches
- Cognitive Behavioral Therapy for Insomnia (CBT-I) is strongly recommended as first-line treatment for chronic insomnia 1, 5
- If medication is necessary, it should be administered at the lowest effective dose for the shortest possible duration 1
- All patients should receive counseling about potential risks of zopiclone 1
While zopiclone was initially believed to have advantages over benzodiazepines in terms of dependence and withdrawal risk, clinical experience over time has shown that its long-term safety profile is concerning and similar to benzodiazepines in many respects 1, 8.